[Strongyloidiasis in the immunologically compromised patient].
D000818:Animals; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008174:Lung Diseases, Parasitic / Q000209:etiology; D051381:Rats; D013322:Strongyloidiasis / Q000150:complications / Q000276:immunology*; D013827:Thiabendazole / Q000627:therapeutic use
D013827:Thiabendazole
Estrongiloidiasis en el paciente inmunocomprometido.